BACKGROUND: Both of prolonged QT interval and elevated C-reactive protein (CRP) levels are known to be risk factors of cardiovascular disease. To our knowledge, few studies have reported the direct relationship between CRP levels and the QT interval in middle-aged population. The objective of the present study was to examine the association of CRP level with QT interval. METHODS AND RESULTS: A total of 2471 men and 2287 women from the Korea n Health and Genome study underwent physical examination and completed a questionnaire. A 12-lead electrocardiogram (ECG) recording was obtained from each subject. Subjects who were taking statins, non-steroidal anti-inflammatory drugs (NSAID) and postmenopausal hormone replacement therapy, which are known to have an effect on CRP levels, were excluded. Geometric means of CRP levels were compared among three groups, which were classified by heart rate-corrected QT (QTc) interval: prolonged (> or =440 msec in men and > or =450 msec in women), borderline (420-439 msec in men and 430-449 msec in women) and normal (<420 msec in men and <430 msec in women) groups. The means of CRP level in women, though over normal range, increased significantly as QTc interval was longer, independent of confounding factors, while those of men were on the borderline of significance. However, compared to normal range of QTc interval, prolonged QTc interval was associated with elevated CRP level, defined as more than 95 percentile of CRP, in men and women, respectively. CONCLUSIONS: Prolonged QTc interval in middle-aged men and women is associated with the elevated CRP, independent of confounding factors.
BACKGROUND: Both of prolonged QT interval and elevated C-reactive protein (CRP) levels are known to be risk factors of cardiovascular disease. To our knowledge, few studies have reported the direct relationship between CRP levels and the QT interval in middle-aged population. The objective of the present study was to examine the association of CRP level with QT interval. METHODS AND RESULTS: A total of 2471 men and 2287 women from the Korea n Health and Genome study underwent physical examination and completed a questionnaire. A 12-lead electrocardiogram (ECG) recording was obtained from each subject. Subjects who were taking statins, non-steroidal anti-inflammatory drugs (NSAID) and postmenopausal hormone replacement therapy, which are known to have an effect on CRP levels, were excluded. Geometric means of CRP levels were compared among three groups, which were classified by heart rate-corrected QT (QTc) interval: prolonged (> or =440 msec in men and > or =450 msec in women), borderline (420-439 msec in men and 430-449 msec in women) and normal (<420 msec in men and <430 msec in women) groups. The means of CRP level in women, though over normal range, increased significantly as QTc interval was longer, independent of confounding factors, while those of men were on the borderline of significance. However, compared to normal range of QTc interval, prolonged QTc interval was associated with elevated CRP level, defined as more than 95 percentile of CRP, in men and women, respectively. CONCLUSIONS: Prolonged QTc interval in middle-aged men and women is associated with the elevated CRP, independent of confounding factors.
Authors: Anthony R Magnano; Steve Holleran; Rajasekhar Ramakrishnan; James A Reiffel; Daniel M Bloomfield Journal: J Am Coll Cardiol Date: 2002-06-05 Impact factor: 24.094
Authors: A Gastaldelli; M Emdin; F Conforti; S Camastra; E Ferrannini Journal: Am J Physiol Regul Integr Comp Physiol Date: 2000-12 Impact factor: 3.619
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Arduino A Mangoni; Richard J Woodman; Paraskevi Gaganis; Andrew L Gilbert; Kathleen M Knights Journal: Br J Clin Pharmacol Date: 2010-06 Impact factor: 4.335
Authors: Jonathan M Kocarnik; Melissa Richard; Misa Graff; Jeffrey Haessler; Stephanie Bien; Chris Carlson; Cara L Carty; Alexander P Reiner; Christy L Avery; Christie M Ballantyne; Andrea Z LaCroix; Themistocles L Assimes; Maja Barbalic; Nathan Pankratz; Weihong Tang; Ran Tao; Dongquan Chen; Gregory A Talavera; Martha L Daviglus; Diana A Chirinos-Medina; Rocio Pereira; Katie Nishimura; Petra Bužková; Lyle G Best; José Luis Ambite; Iona Cheng; Dana C Crawford; Lucia A Hindorff; Myriam Fornage; Gerardo Heiss; Kari E North; Christopher A Haiman; Ulrike Peters; Loic Le Marchand; Charles Kooperberg Journal: Hum Mol Genet Date: 2018-08-15 Impact factor: 6.150
Authors: Nino Isakadze; Marc C Engels; Dominik Beer; Rebecca McClellan; Lisa R Yanek; Bahareh Mondaloo; Allison G Hays; Thomas S Metkus; Hugh Calkins; Andreas S Barth Journal: Front Cardiovasc Med Date: 2022-06-23
Authors: Daniel Medenwald; Jan A Kors; Harald Loppnow; Joachim Thiery; Alexander Kluttig; Sebastian Nuding; Daniel Tiller; Karin H Greiser; Karl Werdan; Johannes Haerting Journal: PLoS One Date: 2014-04-25 Impact factor: 3.240
Authors: Jan Szewieczek; Zbigniew Gąsior; Jan Duława; Tomasz Francuz; Katarzyna Legierska; Agnieszka Batko-Szwaczka; Beata Hornik; Magdalena Janusz-Jenczeń; Iwona Włodarczyk; Krzysztof Wilczyński Journal: Age (Dordr) Date: 2016-04-02
Authors: Siqi Zhang; Susanne Breitner; Wayne E Cascio; Robert B Devlin; Lucas M Neas; David Diaz-Sanchez; William E Kraus; Joel Schwartz; Elizabeth R Hauser; Annette Peters; Alexandra Schneider Journal: Part Fibre Toxicol Date: 2018-10-11 Impact factor: 9.400